Home
About
Services
Partners
Client Portfolio
News
Contact
Senate to grill Facebook over plans for Libra cryptocurrency
July 16, 2019
Barclays sees Carrefour-Casino merger as possible, pushing up Casino shares
July 16, 2019
0
Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook
Published by
Muller&Green
at
July 16, 2019
Categories
RSS
Tags
Johnson & Johnson hiked its full-year operational sales forecast as strong demand for its cancer drugs Darzalex and Imbruvica helped it beat estimates for second-quarter profit on Tuesday.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more